• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Interplay of diabetes and coronary heart disease on cardiovascular mortality.糖尿病与冠心病对心血管死亡率的相互作用。
Heart. 2004 Dec;90(12):1371-3. doi: 10.1136/hrt.2004.035766.
2
[Type 2 diabetes mellitus and coronary heart disease].
Schweiz Med Wochenschr. 1999 May 8;129(18):700-6.
3
Cardiovascular disease and intensive glucose lowering in type 2 diabetes.2型糖尿病中的心血管疾病与强化降糖
QJM. 2009 Apr;102(4):293-6. doi: 10.1093/qjmed/hcp001. Epub 2009 Jan 15.
4
Glucose-lowering therapy after myocardial infarction: more questions than answers.心肌梗死后的降糖治疗：问题多于答案。
Eur Heart J. 2008 Jan;29(2):141-3. doi: 10.1093/eurheartj/ehm595.
5
Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.二甲双胍对心血管事件和死亡率的影响：随机临床试验的荟萃分析。
Diabetes Obes Metab. 2011 Mar;13(3):221-8. doi: 10.1111/j.1463-1326.2010.01349.x.
6
Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS).血脂康，一种红曲提取物，可降低2型糖尿病合并冠心病患者的心血管事件：中国冠心病二级预防研究（CCSPS）中2型糖尿病患者的亚组分析。
J Cardiovasc Pharmacol. 2007 Feb;49(2):81-4. doi: 10.1097/FJC.0b013e31802d3a58.
7
Serious cardiovascular outcomes in diabetes: the role of hypoglycemia.糖尿病患者的严重心血管结局：低血糖的作用。
Circulation. 2011 Jan 25;123(3):342-8. doi: 10.1161/CIRCULATIONAHA.110.948489.
8
Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population.高危人群使用格列本脲（优降糖）或格列齐特治疗期间的心血管不良事件。
Diabet Med. 2012 Dec;29(12):1524-8. doi: 10.1111/j.1464-5491.2012.03772.x.
9
Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).磺脲类药物抗糖尿病治疗对2型糖尿病患者急性心肌梗死后长期生存的影响。朗根德雷尔糖尿病患者心肌梗死与血糖评估研究（LAMBDA）。
Exp Clin Endocrinol Diabetes. 2003 Sep;111(6):344-50. doi: 10.1055/s-2003-42725.
10
Primary prevention of cardiovascular disease in people with dysglycemia.血糖异常人群心血管疾病的一级预防
Diabetes Care. 2008 Feb;31 Suppl 2:S208-14. doi: 10.2337/dc08-s256.

引用本文的文献

1
Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus.非白蛋白尿的 2 型糖尿病患者与非糖尿病患者炎症、血红蛋白水平与冠状动脉疾病的相关性。
Int J Mol Sci. 2023 Sep 15;24(18):14131. doi: 10.3390/ijms241814131.
2
Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks.在 2 型糖尿病伴极高动脉粥样硬化风险患者中，他汀类药物与依折麦布联合他汀类药物的降脂强度相当时，纯他汀类药物与依折麦布联合他汀类药物的主要心血管结局相似。
Sci Rep. 2021 Mar 23;11(1):6697. doi: 10.1038/s41598-021-86090-9.
3
Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke.维格列汀治疗急性冠脉综合征或急性缺血性脑卒中后 2 型糖尿病患者的心血管结局。
J Diabetes Investig. 2020 Jan;11(1):110-124. doi: 10.1111/jdi.13078. Epub 2019 Jun 17.
4
Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus.在2型糖尿病年轻患者中，二肽基肽酶-4抑制剂维格列汀降低心血管风险的可能因素。
Diabetes Ther. 2018 Feb;9(1):27-36. doi: 10.1007/s13300-017-0329-5. Epub 2017 Nov 13.
5
Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).冠状动脉疾病是慢性肾脏病、2型糖尿病和贫血患者进展至透析的预测因素：促红细胞生成素治疗减少心血管事件试验（TREAT）分析
J Am Heart Assoc. 2016 Apr 23;5(4):e002850. doi: 10.1161/JAHA.115.002850.
6
Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.紫杉醇和依维莫司洗脱支架植入后 3 个月在链脲佐菌素诱导的糖尿病猪冠状动脉中的比较血管反应。
Cardiovasc Diabetol. 2012 Jun 21;11:75. doi: 10.1186/1475-2840-11-75.
7
Intracardiac intracellular angiotensin system in diabetes.心脏细胞内肾素-血管紧张素系统与糖尿病
Am J Physiol Regul Integr Comp Physiol. 2012 Mar 1;302(5):R510-7. doi: 10.1152/ajpregu.00512.2011. Epub 2011 Dec 14.
8
The intracellular renin-angiotensin system in the heart.心脏中的细胞内肾素-血管紧张素系统。
Curr Hypertens Rep. 2009 Apr;11(2):104-10. doi: 10.1007/s11906-009-0020-y.
9
Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine.在糖尿病猪中，西罗莫司洗脱支架植入后六个月仍存在新生内膜增生。
Cardiovasc Diabetol. 2007 Jun 5;6:16. doi: 10.1186/1475-2840-6-16.
10
A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UK.一项针对英国2型糖尿病治疗中吡格列酮和罗格列酮的终生模拟经济评估。
Pharmacoeconomics. 2007;25(1):39-54. doi: 10.2165/00019053-200725010-00005.

本文引用的文献

1
Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease.老年糖尿病男性和冠心病男性的心血管疾病发病率及死亡率
Heart. 2004 Dec;90(12):1398-403. doi: 10.1136/hrt.2003.026104.
2
Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction.有或无心肌梗死病史的糖尿病和非糖尿病成年人的心血管事件
Circulation. 2004 Feb 24;109(7):855-60. doi: 10.1161/01.CIR.0000116389.61864.DE. Epub 2004 Feb 2.
3
Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study.2型糖尿病患者的心血管事件：与无心血管疾病和有既往心血管疾病的非糖尿病个体的比较。霍恩研究的10年随访
Eur Heart J. 2003 Aug;24(15):1406-13. doi: 10.1016/s0195-668x(03)00197-0.
4
The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men.糖尿病和既往心肌梗死对男性全因死亡率及冠心病死亡率的影响。
J Am Coll Cardiol. 2002 Sep 4;40(5):954-60. doi: 10.1016/s0735-1097(02)02044-2.
5
Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies.2型糖尿病患者与心肌梗死患者心血管风险的比较：横断面研究与队列研究
BMJ. 2002 Apr 20;324(7343):939-42. doi: 10.1136/bmj.324.7343.939.
6
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.氯沙坦干预降低高血压终点事件研究（LIFE）中糖尿病患者的心血管发病率和死亡率：一项与阿替洛尔对比的随机试验
Lancet. 2002 Mar 23;359(9311):1004-10. doi: 10.1016/S0140-6736(02)08090-X.
7
The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up.糖尿病对女性全因死亡率和冠心病死亡率的影响：20年随访研究
Arch Intern Med. 2001 Jul 23;161(14):1717-23. doi: 10.1001/archinte.161.14.1717.
8
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).国家胆固醇教育计划（NCEP）成人高血胆固醇检测、评估与治疗专家小组第三次报告（成人治疗小组第三次报告）执行摘要
JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.
9
Diabetes and all-cause and coronary heart disease mortality among US male physicians.美国男性医生中的糖尿病、全因死亡率和冠心病死亡率
Arch Intern Med. 2001 Jan 22;161(2):242-7. doi: 10.1001/archinte.161.2.242.
10
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.雷米普利对糖尿病患者心血管和微血管结局的影响：HOPE研究及MICRO-HOPE子研究结果。心脏结局预防评估研究组。
Lancet. 2000 Jan 22;355(9200):253-9.

糖尿病与冠心病对心血管死亡率的相互作用。

Interplay of diabetes and coronary heart disease on cardiovascular mortality.

作者信息

Boccara F, Cohen A

出版信息

Heart. 2004 Dec;90(12):1371-3. doi: 10.1136/hrt.2004.035766.

DOI:10.1136/hrt.2004.035766
PMID:15547003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1768583/
Abstract

Patients with both diabetes mellitus and prior myocardial infarction are at particularly high risk for cardiovascular mortality.

摘要

患有糖尿病且既往有心肌梗死病史的患者心血管死亡风险特别高。